Dare Bioscience Inc (DARE)

Currency in USD
1.9200
-0.1200(-5.88%)
Closed·
After Hours
1.9300+0.0100(+0.52%)
·

DARE Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.50 / -0.02
Revenue / Forecast
25.43K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
03/2025-0.5/-0.0225.43K/---2,400%--Free Sign Up
12/2024-0.69/-0.043-63,650/2.73M-1,493.53%-102.33%Free Sign Up
06/2024--/0.023--/522.67K----Free Sign Up
03/2024-0.07/-0.069.3M/173.67K-16.67%+5,254.98%Free Sign Up
12/2023-0.07/-0.0881.81M/2.38M+20.45%-23.95%Free Sign Up
09/2023-0.091/-0.0981M/733.33K+7.04%+36.36%Free Sign Up
06/2023-0.1/-0.1850K/1.1M0%-22.73%Free Sign Up
03/2023-0.09/-0.09--/2.5M0%-100%Free Sign Up
12/2022-0.19/-0.137--/---38.99%--Free Sign Up
09/2022-0.08/-0.117--/7.96M+31.45%-100%Free Sign Up

All numbers in

Dare Bioscience Inc Earnings Call Summary for Q1/2025

  • Dare Bioscience reported a $4.4M loss in Q1 2025, with plans to launch 4 new products and generate revenue by Q4 2025
  • G&A expenses reduced by 14%, R&D expenses by 31% compared to Q1 2024; working capital deficit of $9.4M reported
  • Company maintains positive cash position relative to debt; stock closed at $2.88, near 52-week low of $2.67
  • Sildenafil Cream Phase III study submission targeted for Q2; Ovaprene Phase III and DARE HPV Phase II studies ongoing
  • CEO emphasizes unique market position in women's health, forecasts EPS of -0.72 USD for Q2 and Q3 2025
Last Updated: 13/05/2025, 22:24
Read Full Transcript

FAQ

What Is Dare Bioscience's Earnings Per Share (TTM)?

The Dare Bioscience EPS (TTM) is -0.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.